Wattle's wealth triples in four months
Wattle Health has tripled the wealth of early investors in its ASX float and demand for its latest capital raising has been strong.
Wattle Health has tripled the wealth of early investors in its ASX float and demand for its latest capital raising has been strong.
Researchers have found a way to reliably remove disease-causing mutations from human embryos.
ResMed chief executive Mick Farrell said he is confident mask growth will improve this year after it was affected by manufacture and supply issues.
ASX-listed health technology company Osprey Medical is seeking a $32.5 million equity injection.
This smart, senior partner at PwC wasn't interested in the little envelope the government sent him on his 50th birthday. Luckily his wife persisted.
Mismatched sleep schedules and restless nights may be an evolutionary leftover.
Cochlear CEO Chris Smith's departure after just two years in the top job follows a failed understanding the Colorado-based executive would m...
The sudden retirement of homegrown hearing implant maker Cochlear's American chief executive Chris Smith has left investors puzzled.
Hearing implant maker Cochlear has announced its chief executive officer Chris Smith will retire next January.
The federal government will subsidise a costly, but highly effective, cancer drug.
Enjoy unlimited access to Australia's best business news and market insights across desktop, tablet and mobile
Already a subscriber? Log in